{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:12:19Z","timestamp":1787062339557,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11906-023-01291-z","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T03:02:10Z","timestamp":1703559730000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cell-Free Nucleic Acids for Early Prediction of Preeclampsia"],"prefix":"10.1007","volume":"26","author":[{"given":"Mira N.","family":"Moufarrej","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia D.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Quake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"issue":"6","key":"1291_CR1","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tun\u00e7alp \u00d6, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u201333.","journal-title":"Lancet Glob Health"},{"issue":"5","key":"1291_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275\u201389.","journal-title":"Nat Rev Nephrol"},{"issue":"366","key":"1291_CR3","doi-asserted-by":"publisher","first-page":"l2381","DOI":"10.1136\/bmj.l2381","volume":"15","author":"GJ Burton","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;15(366):l2381.","journal-title":"BMJ"},{"issue":"1","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia Nat Rev Dis Primers. 2023;9(1):8.","journal-title":"Pre-eclampsia Nat Rev Dis Primers"},{"key":"1291_CR5","doi-asserted-by":"crossref","unstructured":"Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2).","DOI":"10.1161\/CIRCOUTCOMES.116.003497"},{"issue":"360","key":"1291_CR6","doi-asserted-by":"publisher","first-page":"j5855","DOI":"10.1136\/bmj.j5855","volume":"24","author":"A Hackshaw","year":"2018","unstructured":"Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;24(360):j5855.","journal-title":"BMJ"},{"key":"1291_CR7","doi-asserted-by":"crossref","unstructured":"\u2022Moufarrej MN, Bianchi DW, Shaw GM, Stevenson DK, Quake SR. Noninvasive prenatal testing using circulating DNA and RNA: advances, challenges, and possibilities. Annu Rev Biomed Data Sci. 2023;6:397\u2013418. This review details the advances in noninvasive prenatal testing in the past decade and provides a lens to assess the impact of liquid biopsy testing on prenatal care more generally.","DOI":"10.1146\/annurev-biodatasci-020722-094144"},{"key":"1291_CR8","doi-asserted-by":"crossref","unstructured":"\u2022Rasmussen M, Reddy M, Nolan R, Camunas-Soler J, Khodursky A, Scheller NM, et al. RNA profiles reveal signatures of future health and disease in pregnancy. Nature. 2022;601(7893):422\u20137. This study along with Moufarrej et al. (2022) demonstrates the utility of cell-free RNA to predict risk of preeclampsia. This work focused on cell-free RNA\u2019s utility as a predictor in the early second trimester.","DOI":"10.1038\/s41586-021-04249-w"},{"key":"1291_CR9","doi-asserted-by":"crossref","unstructured":"\u2022Moufarrej MN, Vorperian SK, Wong RJ, Campos AA, Quaintance CC, Sit RV, et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature. 2022;602(7898):689\u201394. This study along with Rasmussen et al. (2022) demonstrates the utility of cell-free RNA to predict risk of preeclampsia. This work focused on cell-free RNA\u2019s utility as a predictor in across gestation and especially in the first trimester.","DOI":"10.1038\/s41586-022-04410-z"},{"key":"1291_CR10","doi-asserted-by":"crossref","unstructured":"\u2022De Borre M, Che H, Yu Q, Lannoo L, De Ridder K, Vancoillie L, et al. Cell-free DNA methylome analysis for early preeclampsia prediction. Nat Med. 2023;28. This study demonstrates the utility of cell-free DNA to predict risk of early-onset preeclampsia.","DOI":"10.1038\/s41591-023-02510-5"},{"issue":"6393","key":"1291_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1126\/science.aar3819","volume":"360","author":"TTM Ngo","year":"2018","unstructured":"Ngo TTM, Moufarrej MN, Rasmussen M-LH, Camunas-Soler J, Pan W, Okamoto J, et al. Noninvasive blood tests for fetal development predict gestational age and preterm delivery. Science. 2018;360(6393):1133\u20136.","journal-title":"Science"},{"issue":"11","key":"1291_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1373\/clinchem.2017.273888","volume":"63","author":"W Pan","year":"2017","unstructured":"Pan W, Ngo TTM, Camunas-Soler J, Song C-X, Kowarsky M, Blumenfeld YJ, et al. Simultaneously monitoring immune response and microbial infections during pregnancy through plasma cfRNA sequencing. Clin Chem. 2017;63(11):1695\u2013704.","journal-title":"Clin Chem"},{"key":"1291_CR13","doi-asserted-by":"crossref","unstructured":"Linthorst J, Welkers MRA, Sistermans EA. Clinically relevant DNA viruses in pregnancy. Prenat Diagn. 2022;15.","DOI":"10.1002\/pd.6116"},{"key":"1291_CR14","doi-asserted-by":"crossref","unstructured":"Linthorst J, Baksi MMM, Welkers MRA, Sistermans EA. The cell-free DNA virome of 108,349 Dutch pregnant women. Prenat Diagn. 2022;11.","DOI":"10.1002\/pd.6143"},{"issue":"1","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1038\/s41598-018-22414-6","volume":"8","author":"V Chesnais","year":"2018","unstructured":"Chesnais V, Ott A, Chaplais E, Gabillard S, Pallares D, Vauloup-Fellous C, et al. Using massively parallel shotgun sequencing of maternal plasmatic cell-free DNA for cytomegalovirus DNA detection during pregnancy: a proof of concept study. Sci Rep. 2018;8(1):4321.","journal-title":"Sci Rep"},{"issue":"2","key":"1291_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cell.2018.08.016","volume":"175","author":"S Liu","year":"2018","unstructured":"Liu S, Huang S, Chen F, Zhao L, Yuan Y, Francis SS, et al. Genomic analyses from non-invasive prenatal testing reveal genetic associations, patterns of viral infections, and chinese population history. Cell. 2018;175(2):347-359.e14.","journal-title":"Cell"},{"issue":"1","key":"1291_CR17","doi-asserted-by":"publisher","first-page":"72.e1","DOI":"10.1016\/j.ajog.2022.04.002","volume":"227","author":"J Camunas-Soler","year":"2022","unstructured":"Camunas-Soler J, Gee EPS, Reddy M, Mi JD, Thao M, Brundage T, et al. Predictive RNA profiles for early and very early spontaneous preterm birth. Am J Obstet Gynecol. 2022;227(1):72.e1-72.e16.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1291_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000336662","volume":"31","author":"S Roberge","year":"2012","unstructured":"Roberge S, Villa P, Nicolaides K, Gigu\u00e8re Y, Vainio M, Bakthi A, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141\u20136.","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"1291_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","volume":"216","author":"S Roberge","year":"2017","unstructured":"Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110-120.e6.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1291_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajog.2023.04.023","volume":"229","author":"JM Roberts","year":"2023","unstructured":"Roberts JM, King TL, Barton JR, Beck S, Bernstein IM, Buck TE, et al. Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. Am J Obstet Gynecol. 2023;229(3):193\u2013213.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1291_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fpubh.2017.00307","volume":"20","author":"R Trevethan","year":"2017","unstructured":"Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;20(5):307.","journal-title":"Front Public Health"},{"key":"1291_CR22","unstructured":"Organization WH. Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division: executive summary. 2019."},{"issue":"6","key":"1291_CR23","doi-asserted-by":"publisher","first-page":"e2317641","DOI":"10.1001\/jamanetworkopen.2023.17641","volume":"6","author":"DA Fink","year":"2023","unstructured":"Fink DA, Kilday D, Cao Z, Larson K, Smith A, Lipkin C, et al. Trends in maternal mortality and severe maternal morbidity during delivery-related hospitalizations in the United States, 2008 to 2021. JAMA Netw Open. 2023;6(6):e2317641.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1291_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672\u201383.","journal-title":"N Engl J Med"},{"key":"1291_CR25","doi-asserted-by":"crossref","unstructured":"Thadhani R, Lemoine E, Rana S, Costantine MM, Calsavara VF, Boggess K, et al. Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM evid. 2022;9.","DOI":"10.1056\/EVIDoa2200161"},{"issue":"6","key":"1291_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/uog.6244","volume":"32","author":"R Akolekar","year":"2008","unstructured":"Akolekar R, Zaragoza E, Poon LCY, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(6):732\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1291_CR27","doi-asserted-by":"crossref","unstructured":"Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2S):S1071\u2013S1097.e2.","DOI":"10.1016\/j.ajog.2020.07.020"},{"issue":"1","key":"1291_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8\u201315.","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"1291_CR29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756\u201360.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"1291_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000335366","volume":"31","author":"LCY Poon","year":"2012","unstructured":"Poon LCY, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11\u201313 weeks\u2019 gestation. Fetal Diagn Ther. 2012;31(1):42\u20138.","journal-title":"Fetal Diagn Ther"},{"issue":"5","key":"1291_CR31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/uog.13275","volume":"43","author":"L Velauthar","year":"2014","unstructured":"Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women. Ultrasound Obstet Gynecol. 2014;43(5):500\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"1291_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/uog.13435","volume":"44","author":"N Oliveira","year":"2014","unstructured":"Oliveira N, Magder LS, Blitzer MG, Baschat AA. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol. 2014;44(3):279\u201385.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"1291_CR33","doi-asserted-by":"publisher","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","volume":"221","author":"P Chaemsaithong","year":"2019","unstructured":"Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221(6):650.e1-650.e16.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-023-01291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-023-01291-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-023-01291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T04:34:18Z","timestamp":1709181258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-023-01291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s11906-023-01291-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]},"assertion":[{"value":"7 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"S. R. Q. is a founder, consultant, and shareholder of Mirvie and receives royalties from Stanford University from patents on NIPT. M. N. M. is also a shareholder of Mirvie and receives royalties from the Stanford University from patents on NIPT. M. N. M. and S. R. Q. are inventors on a patent application submitted by the Chan Zuckerberg Biohub and Stanford University that covers noninvasive early prediction of preeclampsia and monitoring maternal organ health over pregnancy (US Patent and Trademark Office application numbers 63\/159,400, filed on March 10, 2021, and 63\/276,467, filed on November 5, 2021). The other author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is a review article and does not contain any novel, previously unreported data from human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}